🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Shandong Lukang Pharmaceutical Co Ltd (600789)

Shanghai
Currency in CNY
9.10
+0.10(+1.11%)
Closed

600789 Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa3,732.724,205.114,923.785,621.446,146.72
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+12.11%+12.66%+17.09%+14.17%+9.34%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa2,717.23,246.863,776.94,415.784,685.95
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa1,015.52958.251,146.881,205.661,460.77
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1.5%-5.64%+19.68%+5.13%+21.16%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa27.21%22.79%23.29%21.45%23.77%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa872.05847.251,003.511,011.61,194.63
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+3.66%-2.84%+18.44%+0.81%+18.09%
aa.aaaa.aaaa.aaaa.aaaa.aa140.85192.63266.03264345.79
aa.aaaa.aaaa.aaaa.aaaa.aa701.99627.46699.44696.44811.19
aa.aaaa.aaaa.aaaa.aaaa.aa29.2127.1638.0451.1637.65
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa143.47111.01143.37194.06266.14
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-9.92%-22.63%+29.15%+35.36%+37.14%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa3.84%2.64%2.91%3.45%4.33%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-35.84-51.77-58.21-90.86-70.23
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-19.95%-44.45%-12.42%-56.09%+22.7%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-56.78-63.35-65.13-98.04-79.17
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa20.9411.576.927.198.94
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1.95-13.46-10.1413.640.29
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa109.5845.7775.02116.85196.2
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-0.56201.03-0.382.650.28
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa39.715.4242.1237.1383.7
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa148.82262.16113.58150.1272.98
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-22.62%+76.16%-56.68%+32.15%+81.87%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa3.99%6.23%2.31%2.67%4.44%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa20.0328.6823.696.9816.19
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa128.79233.4889.89143.11256.79
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-7.54-5.61-0.79-5.1-10.62
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa121.25227.8889.1138.01246.17
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-24.87%+87.94%-60.9%+54.9%+78.37%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa3.25%5.42%1.81%2.46%4%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa121.25227.8889.1138.01246.17
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.140.260.10.160.28
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-26.32%+85.71%-61.54%+60%+75%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa0.140.250.10.150.28
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-26.32%+78.57%-60%+50%+86.67%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa866.08876.45890.99862.58879.18
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa866.08911.51890.99920.09879.18
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa0.050.060.050.050.09
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+46.1%+22.22%-9.09%0%+80%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa330.41354.94450.83542.18646.98
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+4.16%+7.42%+27.02%+20.26%+19.33%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa8.85%8.44%9.16%9.64%10.53%
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa143.47111.01143.37194.06266.14
* In Millions of CNY (except for per share items)